Eva Temkin

Acting Director of Policy, Office of Therapeutic Biologics and Biosimilars, CDER
Eva Temkin is the Acting Director for Policy in CDER’s Office of Therapeutics and Biologics, overseeing regulatory policy related to biosimilar, interchangeable, and other therapeutic biologic products. Ms. Temkin is also the lead for FDA’s Biosimilar Action Plan, which outlines the Administration’s plans for encouraging innovation and competition among biologics and biosimilars. Previously, Ms. Temkin was Associate Chief Counsel in FDA’s Office of Chief Counsel, where she counseled CDER on complex issues relevant to drug development and approval. She earned her J.D. from New York University School of Law and B.A. in economics, cum laude, from the University of Michigan.

My Speakers Sessions

Thursday, June 18

5:00pm EDT